Synthesis and Biological Evaluation of 1, 2, 3, 4-Tetrahydroisoquinoline Derivatives as Potent and Selective M2 Muscarinic Receptor Antagonists

A series of 1, 2, 3, 4-tetrahydroisoquinoline derivatives containing the 5, 11-dihydro-6H-pyrido[2, 3-b][1, 4]benzodiazepin-6-one skeleton were prepared and evaluated for their in vitro binding affinities to muscarinic receptors and for antagonism of bradycardia in vivo. Among them, compound 3f had...

Full description

Saved in:
Bibliographic Details
Published inChemical & pharmaceutical bulletin Vol. 47; no. 5; pp. 672 - 677
Main Authors WATANABE, Toshihiro, KINOYAMA, Isao, TAKIZAWA, Kenji, HIRANO, Seiko, SHIBANUMA, Tadao
Format Journal Article
LanguageEnglish
Published Tokyo The Pharmaceutical Society of Japan 1999
Maruzen
Japan Science and Technology Agency
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of 1, 2, 3, 4-tetrahydroisoquinoline derivatives containing the 5, 11-dihydro-6H-pyrido[2, 3-b][1, 4]benzodiazepin-6-one skeleton were prepared and evaluated for their in vitro binding affinities to muscarinic receptors and for antagonism of bradycardia in vivo. Among them, compound 3f had the highest affinity for M2 muscarinic receptors in the heart (pKi=9.1) with low affinity for M3 muscarinic receptors in the submandibular gland. A structure-activity relationship (SAR) study suggested that the benzene ring fused piperidine and the alkyl linker chain lenght are crucially important for increased M2 affinity.
ISSN:0009-2363
1347-5223
DOI:10.1248/cpb.47.672